COVID-19 in patients with hematological malignancies: Considering the role of tyrosine kinase inhibitors.

Autor: Morales-Ortega A; Department of Internal Medicine, Hospital Universitario de Fuenlabrada, Madrid, Spain., García de Tena J; Department of Medicine, Universidad de Alcalá, Madrid, Spain., Frutos-Pérez B; Department of Internal Medicine, Hospital Universitario de Fuenlabrada, Madrid, Spain., Jaenes-Barrios B; Castilla La Nueva Primary Health Care Center, Madrid, Spain., Farfán-Sedano AI; Department of Internal Medicine, Hospital Universitario de Fuenlabrada, Madrid, Spain., Canales-Albendea MÁ; Department of Hematology, Hospital Universitario La Paz, Madrid, Spain., Bernal-Bello D; Department of Internal Medicine, Hospital Universitario de Fuenlabrada, Madrid, Spain.
Jazyk: angličtina
Zdroj: Cancer [Cancer] 2021 Jun 01; Vol. 127 (11), pp. 1937-1938. Date of Electronic Publication: 2021 Mar 15.
DOI: 10.1002/cncr.33432
Databáze: MEDLINE
Externí odkaz: